Should patients with rheumatic diseases take pain medication in order to engage in exercise?
Abstract
Pain is the main symptom in most rheumatic and musculoskeletal diseases (RMDs). It has debilitating effects in terms of mobility, physical function, sleep, mood, fatigue, and overall quality of life. This is why pain and its associates are some of the predominant outcomes evaluated regularly in response to pharmaceutical or any other interventions involved in the management of RMDs.Citation
Metsios, G.S. and Kitas, G.D. (2020) Should patients with rheumatic diseases take pain medication in order to engage in exercise? Expert Review of Clinical Immunology, 16(3), pp. 235-237.Publisher
Taylor & FrancisJournal
Expert Review of Clinical ImmunologyPubMed ID
31928254 (pubmed)Additional Links
https://www.tandfonline.com/doi/full/10.1080/1744666X.2020.1714438Type
Journal articleLanguage
enDescription
This is an accepted manuscript of an article published by Taylor & Francis in Expert Review of Clinical Immunology on 28/01/2020, available online: https://doi.org/10.1080/1744666X.2020.1714438 The accepted version of the publication may differ from the final published version.ISSN
1744-666XEISSN
1744-8409Scopus Count
Collections
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0/